43.16 F
New York
December 13, 2019
Home » MYLAN


Reuters - Business

Mylan shares slide after warning of hit to revenue

(Reuters) – Generic drugmaker Mylan NV (MYL.O) said on Tuesday reevaluation of its portfolio of medicines will continue next year and cautioned of a hit to revenue, and its shares nearly 6%. FILE PHOTO: Logo of Mylan Laboratories, a company primarily engaged in the commercialization of generic drugs is pictured...
Reuters - Business

Mylan to pay $30 million U.S. SEC fine related to EpiPen overcharge probe

(Reuters) – Mylan NV has agreed to pay a $30 million fine to settle U.S. Securities and Exchange Commission charges it hid from investors the impact of a federal probe into the drugmaker’s overbilling the government for its EpiPen allergy treatment. FIlE PHOTO: Logo of Mylan Laboratories, a company primarily...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Click whichever is suitable. Accept Read More